French pharma research company to call Newark home

URLhttp://www.njbiz.com/article/20130124/NJBIZ01/1301
SourceNJBiz
Date Published01/24/2013
Author Namenone
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Biotrial S.A.
Parent companyBiotrial S.A.
Type of work IT
Reshoring category:Transplant
Total number of jobs (added or to be added):60
Year reshoring announced:2013
Year reshoring implemented or to be implemented:2014
Domestically, the work will be done:In-house
Country(ies) from which reshored:France
City reshored to:Newark
State(s) reshored to:NJ
If relevant, work nearshored to:-
Industry(ies):Other, Research/Services
Product(s) reshoredpharmaceutical testing
What non-domestic negative factors made offshoring less attractive?Regulatory compliance
What domestic positive factors made reshoring more attractive?Eco-system synergies, Infrastructure, Skilled workforce availability/training
Find Reshoring Articles